Balraj S Heran

Summary

Country: Canada

Publications

  1. doi Blood pressure lowering efficacy of potassium-sparing diuretics (that block the epithelial sodium channel) for primary hypertension
    Balraj S Heran
    Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada
    Cochrane Database Syst Rev 11:CD008167. 2012
  2. doi Blood pressure lowering efficacy of alpha blockers for primary hypertension
    Balraj S Heran
    Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada
    Cochrane Database Syst Rev 8:CD004643. 2012
  3. doi Angiotensin receptor blockers for heart failure
    Balraj S Heran
    Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada
    Cochrane Database Syst Rev 4:CD003040. 2012
  4. ncbi Overall accuracy of the BpTRU--an automated electronic blood pressure device
    Gurdial S Mattu
    Department of Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada
    Blood Press Monit 9:47-52. 2004
  5. ncbi Comparison of the automated non-invasive oscillometric blood pressure monitor (BpTRU) with the auscultatory mercury sphygmomanometer in a paediatric population
    Gurdial S Mattu
    Department of Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada
    Blood Press Monit 9:39-45. 2004
  6. ncbi Exercise-based cardiac rehabilitation for coronary heart disease
    Balraj S Heran
    Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, 2176 Health Sciences Mall, Vancouver, British Columbia, Canada, V6T 1Z3
    Cochrane Database Syst Rev 7:CD001800. 2011

Collaborators

Detail Information

Publications6

  1. doi Blood pressure lowering efficacy of potassium-sparing diuretics (that block the epithelial sodium channel) for primary hypertension
    Balraj S Heran
    Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada
    Cochrane Database Syst Rev 11:CD008167. 2012
    ..Therefore, it is essential to determine the effects of ENaC blockers on blood pressure (BP), heart rate and withdrawals due to adverse effects (WDAEs) when given as a first-line or second-line therapy...
  2. doi Blood pressure lowering efficacy of alpha blockers for primary hypertension
    Balraj S Heran
    Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada
    Cochrane Database Syst Rev 8:CD004643. 2012
    ..Alpha blockers are occasionally prescribed for hypertension so it is important to determine and compare their effects on blood pressure (BP), heart rate and withdrawals due to adverse effects (WDAE)...
  3. doi Angiotensin receptor blockers for heart failure
    Balraj S Heran
    Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada
    Cochrane Database Syst Rev 4:CD003040. 2012
    ..Chronic heart failure (HF) is a prevalent world-wide. Angiotensin receptor blockers (ARBs) are widely prescribed for chronic HF although their role is controversial...
  4. ncbi Overall accuracy of the BpTRU--an automated electronic blood pressure device
    Gurdial S Mattu
    Department of Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada
    Blood Press Monit 9:47-52. 2004
    ....
  5. ncbi Comparison of the automated non-invasive oscillometric blood pressure monitor (BpTRU) with the auscultatory mercury sphygmomanometer in a paediatric population
    Gurdial S Mattu
    Department of Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada
    Blood Press Monit 9:39-45. 2004
    ..To directly compare the accuracy of the BpTRU (an automated oscillometric blood pressure device) with standard auscultatory mercury sphygmomanometry in a pediatric population...
  6. ncbi Exercise-based cardiac rehabilitation for coronary heart disease
    Balraj S Heran
    Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, 2176 Health Sciences Mall, Vancouver, British Columbia, Canada, V6T 1Z3
    Cochrane Database Syst Rev 7:CD001800. 2011
    ..The burden of coronary heart disease (CHD) worldwide is one of great concern to patients and healthcare agencies alike. Exercise-based cardiac rehabilitation aims to restore patients with heart disease to health...